This inventor holds 2 USPTO granted patents. Top assignees: Purdue Research Foundation, The University of North Carolina at Chapel Hill, Other. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,785 
1 out of 1,327 
1 out of 834,513 Years Active: 2002-2005
Title: Russell A Grubbs: Innovator in Dopamine Receptor Ligands
Introduction
Russell A Grubbs is a notable inventor based in Lafayette, IN (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target dopamine receptors. With a total of 2 patents, his work has the potential to impact various neurological and psychological conditions.
Latest Patents
Grubbs' latest patents include innovative compounds known as Chromeno[4,3,2-de]isoquinolines, which serve as potent dopamine receptor ligands. These novel ligands are described in detail in his patents, which outline pharmaceutical formulations and methods for treating patients suffering from dopamine-related dysfunctions of both the central and peripheral nervous systems. The applications of these compounds are extensive, as they are expected to be useful in treating Parkinson's disease, enhancing cognition and memory, alleviating negative symptoms of schizophrenia, addressing attention-deficit hyperactivity disorder, and managing substance abuse disorders. Furthermore, these compounds may also be beneficial in treating various peripheral conditions where changes in dopamine receptor occupation affect physiological functions, including organ perfusion, cardiovascular function, and selected endocrine and immune system functions.
Career Highlights
Throughout his career, Grubbs has worked at the University of North Carolina at Chapel Hill, where he has contributed to research and development in the field of pharmacology. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Grubbs has collaborated with esteemed colleagues such as David E Nichols and Richard B Mailman. These partnerships have likely enriched his research and contributed to the advancement of his patented technologies.
Conclusion
Russell A Grubbs is a distinguished inventor whose work on dopamine receptor ligands holds promise for treating a variety of neurological and psychological disorders. His contributions to the field of pharmacology are noteworthy and continue to influence ongoing research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile